A New research unit
UMR-S-785 has merged with research unit EA4530 to become Research Unit 1193 (Inserm and University Paris-Sud) on 2015, January 1st. This new research unit is organized with four teams aiming at Physiopathogenesis and treatment of liver diseases.
It is composed of research scientists and clinicians with a considerable reputation and expertise in research areas that range from liver transplantation to therapeutic strategies against fulminant hepatitis and primary liver cancer.
The research unit UMR-S-1193 is located on two sites at the south of Paris :
-
Centre Hépato-Biliaire of Hospital Paul-Brousse, in Villejuif
-
and Faculty of Pharmacy of Université Paris-Sud, in Chatenay-Malabry.